{"nct_id":"NCT02061761","title":"A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies","status":"COMPLETED","status_verified_date":"2023-03","start_date":"2014-03-13","start_date_type":"ACTUAL","primary_completion_date":"2022-02-16","primary_completion_date_type":"ACTUAL","completion_date":"2022-02-16","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["BMY"]}